About: http://webisa.webdatacommons.org/441506841

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	As such, AstraZeneca could start losing ground to Bristol-Myers, Forest, and other companies that are working harder to address their patent cliffs.
http://www.w3.org/ns/prov#wasQuotedFrom	fool.com